PTGDR and lung carcinoma: Enhances the stability of IGF2BP1, c‐Myc and E2F1. Facilitates the c‐Myc/MNX1‐AS1/IGF2BP1 complex to accelerate cell cycle progression and promote lung cancer cell proliferation.